OA13252A - Thienopyrazoles. - Google Patents

Thienopyrazoles. Download PDF

Info

Publication number
OA13252A
OA13252A OA1200600080A OA1200600080A OA13252A OA 13252 A OA13252 A OA 13252A OA 1200600080 A OA1200600080 A OA 1200600080A OA 1200600080 A OA1200600080 A OA 1200600080A OA 13252 A OA13252 A OA 13252A
Authority
OA
OAPI
Prior art keywords
thieno
pyrazol
indol
optionally substituted
piperidin
Prior art date
Application number
OA1200600080A
Other languages
English (en)
Inventor
Matthieu Barrague
Ramalinga M Dharanipragada
Yan Du
Michael Louis Edwards
Timothy Alan Gillespy
John Gerard Jurcak
Kwon Yon Musick
Ashfaq Ahmed Parkar
Philip Marvin Weintraub
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of OA13252A publication Critical patent/OA13252A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
OA1200600080A 2003-09-08 2004-07-23 Thienopyrazoles. OA13252A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50115903P 2003-09-08 2003-09-08

Publications (1)

Publication Number Publication Date
OA13252A true OA13252A (en) 2007-01-31

Family

ID=34312256

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200600080A OA13252A (en) 2003-09-08 2004-07-23 Thienopyrazoles.

Country Status (30)

Country Link
US (2) US7518000B2 (de)
JP (1) JP4879739B2 (de)
KR (1) KR20060069490A (de)
CN (1) CN100398545C (de)
AT (1) ATE468341T1 (de)
AU (1) AU2004272507B2 (de)
BR (1) BRPI0414215A (de)
CA (1) CA2538032C (de)
CR (1) CR8255A (de)
DE (1) DE602004027288D1 (de)
DK (1) DK1682553T3 (de)
EC (1) ECSP066411A (de)
ES (1) ES2345257T3 (de)
HK (1) HK1095587A1 (de)
HR (1) HRP20100398T1 (de)
IL (1) IL173916A (de)
MA (1) MA28038A1 (de)
ME (1) MEP20908A (de)
MX (1) MXPA06001827A (de)
MY (1) MY144339A (de)
NO (1) NO20061626L (de)
NZ (1) NZ545421A (de)
OA (1) OA13252A (de)
PT (1) PT1682553E (de)
RS (2) RS20060162A (de)
RU (1) RU2358978C2 (de)
TN (1) TNSN06058A1 (de)
TW (1) TWI352705B (de)
WO (1) WO2005026175A1 (de)
ZA (1) ZA200601947B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101454A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Benzothiophene derivatives: preparation and pharmaceutical applications
EP1968580A2 (de) * 2005-12-20 2008-09-17 Boehringer Ingelheim International Gmbh 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indol-derivate und damit zusammenhängende verbindungen als tec-kinase-hemmer zur behandlung von entzündungen und immunologischen erkrankungen
EP2151434A1 (de) 2008-08-05 2010-02-10 Institut Pasteur Allkoxypyrazole und Verfahren zu ihrer Herstellung
EP2151433A1 (de) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazole und Verfahren zu ihrer Herstellung
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
US20130158066A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
CN103467481B (zh) * 2012-06-07 2016-08-31 上海汇伦生命科技有限公司 二氢吡啶类化合物、其组合物、制备方法和用途
TW201414734A (zh) 2012-07-10 2014-04-16 Takeda Pharmaceutical 氮雜吲哚衍生物
WO2014041518A1 (en) * 2012-09-14 2014-03-20 Glenmark Pharmaceuticals S.A. Thienopyrrole derivatives as itk inhibitors
CN103720694A (zh) * 2012-10-11 2014-04-16 韩冰 一类治疗脑性瘫痪的化合物及其用途
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
KR101571590B1 (ko) * 2012-11-21 2015-11-25 주식회사 두산 유기 화합물 및 이를 이용하는 유기 전계 발광 소자
CA3103411A1 (en) 2013-10-25 2015-04-30 Pharmacyclics Llc Use of ibrutinib for treating and preventing chronic graft versus host disease
TW201620904A (zh) 2014-01-09 2016-06-16 武田藥品工業有限公司 氮雜吲哚衍生物
WO2016010108A1 (ja) * 2014-07-18 2016-01-21 塩野義製薬株式会社 含窒素複素環誘導体およびそれらを含有する医薬組成物
CN108135904A (zh) 2015-08-31 2018-06-08 药品循环有限责任公司 用于治疗多发性骨髓瘤的btk抑制剂组合
JP2019532997A (ja) 2016-11-03 2019-11-14 ジュノー セラピューティクス インコーポレイテッド Ｔ細胞療法とｂｔｋ阻害剤との併用療法
US20210121466A1 (en) 2018-05-03 2021-04-29 Juno Therapeutics, Inc. Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
WO2023139248A1 (en) * 2022-01-21 2023-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Inhibitors of acyl protein thioesterases against microbial infections
WO2023220655A1 (en) 2022-05-11 2023-11-16 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
WO2001000610A1 (de) * 1999-06-23 2001-01-04 Aventis Pharma Deutschland Gmbh Substituierte benzimidazole
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
WO2003024969A1 (en) * 2001-09-14 2003-03-27 Merck & Co., Inc. Tyrosine kinase inhibitors
IL161576A0 (en) * 2001-10-26 2004-09-27 Aventis Pharma Inc Benzimidazoles and analogues and their use as protein kinases inhibitors
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr

Also Published As

Publication number Publication date
DE602004027288D1 (en) 2010-07-01
ZA200601947B (en) 2007-05-30
IL173916A0 (en) 2006-07-05
ES2345257T3 (es) 2010-09-20
WO2005026175A1 (en) 2005-03-24
JP4879739B2 (ja) 2012-02-22
ECSP066411A (es) 2006-09-18
AU2004272507A1 (en) 2005-03-24
CA2538032C (en) 2011-01-11
NZ545421A (en) 2010-03-26
ATE468341T1 (de) 2010-06-15
US7518000B2 (en) 2009-04-14
PT1682553E (pt) 2010-07-29
CN1849322A (zh) 2006-10-18
CR8255A (es) 2006-07-14
RU2006111470A (ru) 2007-10-27
RS51846B (en) 2012-02-29
MA28038A1 (fr) 2006-07-03
DK1682553T3 (da) 2010-08-23
TW200519118A (en) 2005-06-16
US20100056514A1 (en) 2010-03-04
IL173916A (en) 2011-07-31
US7928231B2 (en) 2011-04-19
RU2358978C2 (ru) 2009-06-20
NO20061626L (no) 2006-04-10
TNSN06058A1 (en) 2007-10-03
JP2007505038A (ja) 2007-03-08
MY144339A (en) 2011-08-29
KR20060069490A (ko) 2006-06-21
MEP20908A (en) 2010-06-10
RS20060162A (en) 2008-06-05
TWI352705B (en) 2011-11-21
MXPA06001827A (es) 2006-05-31
US20070254937A1 (en) 2007-11-01
HK1095587A1 (en) 2007-05-11
HRP20100398T1 (hr) 2010-09-30
AU2004272507B2 (en) 2011-05-12
CN100398545C (zh) 2008-07-02
BRPI0414215A (pt) 2006-11-07
CA2538032A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
US7928231B2 (en) Thienopyrazoles
US11649242B2 (en) Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
KR100883003B1 (ko) 알츠하이머병의 치료를 위한 글라이신 수송체1(ｇｌｙｔ-1) 억제제로서 바이- 및 트라이사이클릭 치환된페닐 메탄온
KR101616140B1 (ko) 복소환 화합물
US7557114B2 (en) Heterocyclic-substituted phenyl methanones
TWI576346B (zh) 雙環吡嗪酮衍生物
US20100029619A1 (en) Fused heterocyclic compound
KR20080009200A (ko) 치환된 헤테로사이클 및 이것의 ｃｈｋ1, ｐｄｋ1 및ｐａｋ 억제제로서의 용도
KR101544290B1 (ko) Kat ii 억제제
KR20150105319A (ko) 감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
US9023858B2 (en) Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors
EP1682553B1 (de) Thienopyrazole
TWI454473B (zh) 稠環化合物及其用途